Structural modifications of HDL and functional consequences

被引:136
作者
Ferretti, G
Bacchetti, T
Nègre-Salvayre, A
Salvayre, R
Dousset, N
Curatola, G
机构
[1] Univ Ancona, Fac Med, Inst Biochem, I-60131 Ancona, Italy
[2] CHU Rangueil, INSERM, UMR 466, Toulouse, France
[3] CHU Rangueil, Dept Biochem, Toulouse, France
[4] Univ Toulouse 3, F-31062 Toulouse, France
关键词
atherosclerosis; high density lipoprotein; oxidation; modification; glycation;
D O I
10.1016/j.atherosclerosis.2005.08.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High density lipoproteins (HDL) are susceptible to structural modifications mediated by various mechanisms including oxidation, glycation, homocysteinylation or enzymatic degradation. Structural alterations of HDL may affect their functional and atheroprotective properties. Oxidants, such as hypochlorous acid, peroxyl radicals, metal ions, peroxynitrite, lipoxygenases and smoke extracts, can alter both surface and core components of HDL. The formation of lipid peroxidation derivatives, such as thiobarbituric acid reactive substances, conjugated dienes, lipid hydroperoxides and aldehydes, is associated with changes of physical properties (fluidity, molecular order) and of apoprotein conformation. Non-enzymatic glycation, generally associated with lipoxidation, leads to form irreversible complexes called advanced glycation end products. These HDL modifications are accompanied with altered biological activities of HDL and associated enzymes, including paraoxonase, CETP and LCAT. Homocysteine-induced modification of HDL is mediated by homocysteine-thiolactone, and can be prevented by a calcium-dependent thiolactonase/paraoxonase. Tyrosylation of HDL induces the formation of dinners and trimers of apo AI, and alters cholesterol efflux. Phospholipases and proteolytic enzymes can also modify HDL lipid and apoprotein structure. HDL modification induces generally the loss of their anti-inflammatory and cytoprotective properties. This could play a role in the pathogenesis of atherosclerosis and neurodegenerative diseases such as Alzheimer's disease. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 69 条
[1]   OXIDIZED HDL ARE MUCH LESS CYTOTOXIC TO LYMPHOBLASTOID-CELLS THAN OXIDIZED LDL [J].
ALOMAR, Y ;
NEGRESALVAYRE, A ;
LEVADE, T ;
VALDIGUIE, P ;
SALVAYRE, R .
BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1128 (2-3) :163-166
[2]   High density lipoprotein and lipoprotein oxidation [J].
Banka, CL .
CURRENT OPINION IN LIPIDOLOGY, 1996, 7 (03) :139-142
[3]   Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo [J].
Bassett, CN ;
Neely, MD ;
Sidell, KR ;
Markesbery, WR ;
Swift, LL ;
Montine, TJ .
LIPIDS, 1999, 34 (12) :1273-1280
[4]  
Bassett CN, 2000, MICROSC RES TECHNIQ, V50, P282, DOI 10.1002/1097-0029(20000815)50:4<282::AID-JEMT6>3.0.CO
[5]  
2-T
[6]   PHYSICOCHEMICAL CHANGES IN HUMAN HIGH-DENSITY-LIPOPROTEINS (HDL) OXIDIZED BY GAMMA RADIOLYSIS-GENERATED OXYRADICALS - EFFECT ON THEIR CHOLESTEROL EFFLUXING CAPACITY [J].
BONNEFONTROUSSELOT, D ;
MOTTA, C ;
KHALIL, AO ;
SOLA, R ;
LAVILLE, AE ;
DELATTRE, J ;
GARDESALBERT, M .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1255 (01) :23-30
[7]   HIGH-DENSITY-LIPOPROTEIN IS THE MAJOR CARRIER OF LIPID HYDROPEROXIDES IN HUMAN BLOOD-PLASMA FROM FASTING DONORS [J].
BOWRY, VW ;
STANLEY, KK ;
STOCKER, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10316-10320
[8]   High-density lipoprotein 3 physicochemical modifications induced by interaction with human polymorphonuclear leucocytes affect their ability to remove cholesterol from cells [J].
Cogny, A ;
Atger, V ;
Paul, JL ;
Soni, T ;
Moatti, N .
BIOCHEMICAL JOURNAL, 1996, 314 :285-292
[9]   HIGH-DENSITY-LIPOPROTEIN AND CEREBRAL ENDOTHELIAL-CELLS IN-VITRO - INTERACTIONS AND TRANSPORT [J].
DEVRIES, HE ;
BREEDVELD, B ;
KUIPER, J ;
DEBOER, AG ;
VANBERKEL, TJC ;
BREIMER, DD .
BIOCHEMICAL PHARMACOLOGY, 1995, 50 (02) :271-273
[10]   NONENZYMATIC GLYCOSYLATION OF HDL AND IMPAIRED HDL-RECEPTOR MEDIATED CHOLESTEROL EFFLUX [J].
DUELL, PB ;
ORAM, JF ;
BIERMAN, EL .
DIABETES, 1991, 40 (03) :377-384